학술논문
190 (PB070) - Iadademstat and gilteritinib synergistically abrogate viability of both treatment-naïve and drug-resistant AML cells
Document Type
Abstract
Source
In European Journal of Cancer October 2022 174 Supplement 1:S68-S68
Subject
Language
ISSN
0959-8049